Theracryf

(TCF)
Sector: Pharma and Biotech
0.52p
-0.02p -4.19
Last updated: 11:00:03

Director dealings

Trade date Director Volume / Price Trade value Trade type
No director deals found.

Major shareholders

Institution name Holding Percent
James Robert Kight 34,600,000 8.10%
First Equity Limited 31,200,000 7.30%
Sarum Investment SICAV Plc 25,700,000 6.01%
Seneca Partners Limited 16,301,456 3.81%